Loading...
•
Jun 30, 2024
Integra LifeSciences Q2 2024 Earnings Report
Integra LifeSciences' financial performance reflected persistent market demand and commitment to enhancing quality and reliability of operations.
Key Takeaways
Integra LifeSciences reported a 9.7% increase in second-quarter revenues to $418.2 million, with a GAAP net loss of $(12.4) million, or $(0.16) per diluted share. Adjusted earnings per diluted share were $0.63. The company is updating its full-year revenue guidance to $1.609 billion to $1.629 billion and adjusted EPS guidance to $2.41 to $2.57.
Second quarter revenues increased 9.7% on a reported basis and 2.3% on an organic basis compared to the prior year.
GAAP earnings per diluted share were $(0.16), compared to $0.05 in the prior year; adjusted earnings per diluted share was $0.63, compared to $0.71 in the prior year.
Early integration success with the Acclarent ENT acquisition.
Updating full-year 2024 revenue guidance to a range of $1.609 billion to $1.629 billion and adjusted EPS guidance to a range of $2.41 to $2.57 per share.
Revenue by Segment
Forward Guidance
The Company is updating its revenue and adjusted EPS expectations to $1.609 to $1.629 billion and $2.41 to $2.57, respectively. For the third quarter 2024, the Company expects reported revenues in the range of $372 million to $382 million, representing reported growth of -2.6% to 0.0% and organic growth of -9.4% to –6.7%. The Company expects adjusted EPS in a range of $0.36 to $0.44.
Positive Outlook
- Revenue range represents reported growth of 4.4% to 5.7%.
- The company expects adjusted EPS in a range of $2.41 to $2.57.
- For the third quarter 2024, the Company expects reported revenues in the range of $372 million to $382 million.
- The Company expects adjusted EPS in a range of $0.36 to $0.44.
Challenges Ahead
- Organic growth of –1.0% to 0.3%, reflecting third quarter quality and labeling compliance shipping holds.
- Significant second half investments in quality and compliance improvement.
- Third quarter organic growth of -9.4% to –6.7%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...